UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Adherence in Glaucoma: Objective Measurements of Once-Daily and Adjunctive Medication Use

American journal of ophthalmology, 2007-10, Vol.144 (4), p.533-540.e2

2007

Volltextzugriff (PDF)

Evaluation of Medicare Costs of Endophthalmitis among Patients after Cataract Surgery

Ophthalmology (Rochester, Minn.), 2007-06, Vol.114 (6), p.1094-1099

2007

Volltextzugriff (PDF)

Two-year treatment patterns and costs in glaucoma patients initiating treatment with prostaglandin analogs

Clinical ophthalmology (Auckland, N.Z.), 2010-01, Vol.4 (default), p.1137-1143

2010

Volltextzugriff (PDF)

Patterns and Costs Associated With Progression of Age-Related Macular Degeneration

American journal of ophthalmology, 2012-10, Vol.154 (4), p.675-681.e1

2012

Volltextzugriff (PDF)

Characteristics of respondents with glaucoma and dry eye in a national panel survey

Clinical ophthalmology (Auckland, N.Z.), 2009-01, Vol.3 (default), p.645-650

2009

Volltextzugriff (PDF)

First-year treatment costs among new initiators of topical prostaglandin analogs: pooled results

Clinical ophthalmology (Auckland, N.Z.), 2010-01, Vol.4 (default), p.437-445

2010

Volltextzugriff (PDF)

Treatment costs of cystoid macular edema among patients following cataract surgery

Clinical ophthalmology (Auckland, N.Z.), 2016-01, Vol.10 (Issue 1), p.477-483

2016

Volltextzugriff (PDF)

First-year treatment costs among new initiators of topical prostaglandin analogs

Clinical ophthalmology (Auckland, N.Z.), 2009-01, Vol.3 (default), p.637-644

2009

Volltextzugriff (PDF)

An updated estimate of costs of endophthalmitis following cataract surgery among Medicare patients: 2010-2014

Clinical ophthalmology (Auckland, N.Z.), 2016-01, Vol.10, p.2121-2127

2016

Volltextzugriff (PDF)

Impact of visual impairment on service and device use by individuals with age-related macular degeneration (AMD)

Disability and rehabilitation, 2006-01, Vol.28 (21), p.1331-1338

2006

Volltextzugriff (PDF)

Adjunctive therapy patterns in glaucoma patients using prostaglandin analogs

Clinical ophthalmology (Auckland, N.Z.), 2014, Vol.8 (default), p.1097-1104

2014

Volltextzugriff (PDF)

Evaluation of costs for cystoid macular edema among patients after cataract surgery

Retina (Philadelphia, Pa.), 2007-06, Vol.27 (5), p.621-628

2007

Volltextzugriff (PDF)

Medicare expenditures associated with diabetes and diabetic retinopathy

Retina (Philadelphia, Pa.), 2009-02, Vol.29 (2), p.199-206

2009

Volltextzugriff (PDF)

First-year treatment patterns among new initiators of topical prostaglandin analogs

Current medical research and opinion, 2009-04, Vol.25 (4), p.851-858

2009

Volltextzugriff (PDF)

Medical Service Encounters and Payments Associated with Topical Adjunctive Therapy Use of Timolol for Glaucoma

Clinical drug investigation, 2012-12, Vol.32 (12), p.835-842

2012

Volltextzugriff (PDF)

First-year treatment costs among new initiators of topical prostaglandin analog identified from November 2007 through April 2008

Current medical research and opinion, 2010-12, Vol.26 (12), p.2769-2777

2010

Volltextzugriff (PDF)

An objective evaluation of eyedrop instillation in patients with glaucoma

Archives of ophthalmology (1960), 2009-06, Vol.127 (6), p.732

2009

Volltextzugriff (PDF)

Anterior Juxtascleral Delivery of Anecortave Acetate in Eyes with Primary Open-Angle Glaucoma: A Pilot Investigation

American journal of ophthalmology, 2009, Vol.147 (1), p.45-50.e2

2009

Volltextzugriff (PDF)

Impact of visual impairment on service and device use by individuals with diabetic retinopathy

Disability and rehabilitation, 2009-01, Vol.31 (8), p.659-665

2009

Volltextzugriff (PDF)

Estimated first-year costs of prostaglandin analogs with/without adjunctive therapy for glaucoma management:a United States perspective

Current medical research and opinion, 2007-11, Vol.23 (11), p.2867-2875

2007

Volltextzugriff (PDF)

Persistence with Prostaglandin Agonist Use with and without Adjunctive Therapy for Glaucoma Patients: A Canadian Population-Based Analysis

The patient : patient-centered outcomes research, 2011, Vol.4 (2), p.133-141

2011

Volltextzugriff (PDF)

Travoprost versus latanoprost combinations in glaucoma:economic evaluation based on visual field deficit progression

Current medical research and opinion, 2006-09, Vol.22 (9), p.1737-1743

2006

Volltextzugriff (PDF)

Trends in annual medicare expenditures for glaucoma surgical procedures from 1997 to 2006

Archives of ophthalmology (1960), 2009-07, Vol.127 (7), p.900

2009

Volltextzugriff (PDF)

Projected impact of travoprost versus both timolol and latanoprost on visual field deficit progression and costs among black glaucoma subjects

Transactions of the American Ophthalmological Society, 2002, Vol.100, p.109-118

2002

Volltextzugriff (PDF)

Persistence with Prostaglandin Agonist Use with and without Adjunctive Therapy for Glaucoma Patients

The patient : patient-centered outcomes research, 2011-06, Vol.4 (2), p.133

2011

Volltextzugriff (PDF)

1 – 25 von 62

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(52)
Mit Volltextzugriff
(50)

Publikationsform

Artikel
(59)
Reviews
(3)

Sprache

Englisch
(62)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Adherence in Glaucoma: Objective Measurements of Once-Daily and Adjunctive Medication Use

Evaluation of Medicare Costs of Endophthalmitis among Patients after Cataract Surgery

Two-year treatment patterns and costs in glaucoma patients initiating treatment with prostaglandin analogs

Patterns and Costs Associated With Progression of Age-Related Macular Degeneration

Characteristics of respondents with glaucoma and dry eye in a national panel survey

First-year treatment costs among new initiators of topical prostaglandin analogs: pooled results

Treatment costs of cystoid macular edema among patients following cataract surgery

First-year treatment costs among new initiators of topical prostaglandin analogs

An updated estimate of costs of endophthalmitis following cataract surgery among Medicare patients: 2010-2014

Impact of visual impairment on service and device use by individuals with age-related macular degeneration (AMD)

Adjunctive therapy patterns in glaucoma patients using prostaglandin analogs

Evaluation of costs for cystoid macular edema among patients after cataract surgery

Medicare expenditures associated with diabetes and diabetic retinopathy

First-year treatment patterns among new initiators of topical prostaglandin analogs

Medical Service Encounters and Payments Associated with Topical Adjunctive Therapy Use of Timolol for Glaucoma

First-year treatment costs among new initiators of topical prostaglandin analog identified from November 2007 through April 2008

An objective evaluation of eyedrop instillation in patients with glaucoma

Anterior Juxtascleral Delivery of Anecortave Acetate in Eyes with Primary Open-Angle Glaucoma: A Pilot Investigation

Impact of visual impairment on service and device use by individuals with diabetic retinopathy

Estimated first-year costs of prostaglandin analogs with/without adjunctive therapy for glaucoma management:a United States perspective

Persistence with Prostaglandin Agonist Use with and without Adjunctive Therapy for Glaucoma Patients: A Canadian Population-Based Analysis

Travoprost versus latanoprost combinations in glaucoma:economic evaluation based on visual field deficit progression

Trends in annual medicare expenditures for glaucoma surgical procedures from 1997 to 2006

Projected impact of travoprost versus both timolol and latanoprost on visual field deficit progression and costs among black glaucoma subjects

Persistence with Prostaglandin Agonist Use with and without Adjunctive Therapy for Glaucoma Patients

Suchergebnisse filtern